Related references
Note: Only part of the references are listed.Anandamide and 2-arachidonoylglycerol differentially modulate autistic-like traits in a genetic model of autism based on FMR1 deletion in rats
Sara Schiavi et al.
NEUROPSYCHOPHARMACOLOGY (2023)
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder et al.
NEUROPSYCHOPHARMACOLOGY (2023)
Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats
Sara Schiavi et al.
NUTRITIONAL NEUROSCIENCE (2022)
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Athanasios Markopoulos et al.
FRONTIERS IN PHARMACOLOGY (2022)
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
Danilo De Gregorio et al.
JOURNAL OF NEUROSCIENCE (2021)
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
L. S. Kaertner et al.
SCIENTIFIC REPORTS (2021)
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property
Guy A. Higgins et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Therapeutic Potential of Psilocybin
Henry Lowe et al.
MOLECULES (2021)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
Alan K. Davis et al.
JAMA PSYCHIATRY (2021)
Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
Ling-Xiao Shao et al.
NEURON (2021)
Behavioral neuroscience of autism
Toru Takumi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Meghan Hibicke et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Role of the Serotonin Receptor 7 in Brain Plasticity: From Development to Disease
Marianna Crispino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings
Matthias Forstmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Psychedelic Psychiatry's Brave New World
David Nutt et al.
CELL (2020)
The emerging role of psilocybin and MDMA in the treatment of mental illness
Hartej Gill et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review
Genis Ona et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
The therapeutic potential of microdosing psychedelics in depression
Kim P. C. Kuypers
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2020)
Serotonin 5-HT4 receptor boosts functional maturation of dendritic spines via RhoA-dependent control of F-actin
Yvonne Schill et al.
COMMUNICATIONS BIOLOGY (2020)
Microdosing psychedelics: Motivations, subjective effects and harm reduction
Toby Lea et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2020)
Deletion of the KH1 Domain of Fmr1 Leads to Transcriptional Alterations and Attentional Deficits in Rats
Carla E. M. Golden et al.
CEREBRAL CORTEX (2019)
A Synaptic Perspective of Fragile X Syndrome and Autism Spectrum Disorders
Claudia Bagni et al.
NEURON (2019)
Sex Differences in the Behavioral and Synaptic Consequences of a Single in vivo Exposure to the Synthetic Cannabimimetic WIN55,212-2 at Puberty and Adulthood
Milene Borsoi et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2019)
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
Kim P. C. Kuypers et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2019)
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects
Lukasz Smigielski et al.
NEUROIMAGE (2019)
Reward-Related Behavioral, Neurochemical and Electrophysiological Changes in a Rat Model of Autism Based on Prenatal Exposure to Valproic Acid
Sara Schiavi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Prenatal vaiproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder
Anna Maria Tartaglione et al.
NEUROPHARMACOLOGY (2019)
Psychiatry & the psychedelic drugs. Past, present & future
James J. H. Rucker et al.
NEUROPHARMACOLOGY (2018)
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Lindsay P. Cameron et al.
ACS CHEMICAL NEUROSCIENCE (2018)
Modelling fragile X syndrome in the laboratory setting: A behavioral perspective
Francesca Melancia et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats
Rachel R. Horsley et al.
BEHAVIOURAL PHARMACOLOGY (2018)
Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling
Francesca Melancia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid
Michela Servadio et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Psychedelics: Where we are now, why we got here, what we must do
Sean J. Belouin et al.
NEUROPHARMACOLOGY (2018)
Psychosocial Treatments Targeting Anxiety and Depression in Adolescents and Adults on the Autism Spectrum: Review of the Latest Research and Recommended Future Directions
Susan W. White et al.
CURRENT PSYCHIATRY REPORTS (2018)
Activation of Serotonin 5-HT7 Receptors Modulates Hippocampal Synaptic Plasticity by Stimulation of Adenylate Cyclases and Rescues Learning and Behavior in a Mouse Model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Effect of Psilocybin on Empathy and Moral Decision-Making
Thomas Pokorny et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons
Luisa Speranza et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Amplification of mGlu5-Endocannabinoid Signaling Rescues Behavioral and Synaptic Deficits in a Mouse Model of Adolescent and Adult Dietary Polyunsaturated Fatty Acid Imbalance
Antonia Manduca et al.
JOURNAL OF NEUROSCIENCE (2017)
How serotonin receptors regulate morphogenic signalling in neurons
Alexander Wirth et al.
PROGRESS IN NEUROBIOLOGY (2017)
Multifarious Functions of the Fragile X Mental Retardation Protein
Jenna K. Davis et al.
TRENDS IN GENETICS (2017)
Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats
Yonglu Tian et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Fragile X syndrome
Randi J. Hagerman et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
Filip Tyls et al.
BEHAVIOURAL PHARMACOLOGY (2016)
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Stephen Ross et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management
Randi J. Hagerman et al.
NATURE REVIEWS NEUROLOGY (2016)
THE SEROTONIN SYSTEM IN AUTISM SPECTRUM DISORDER: FROM BIOMARKER TO ANIMAL MODELS
C. L. Muller et al.
NEUROSCIENCE (2016)
Effects of serotonin 2A/1A receptor stimulation on social exclusion processing
Katrin H. Preller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats
Yuichi Sakashita et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Conserved hippocampal cellular pathophysiology but distinct behavioural deficits in a new rat model of FXS
Sally M. Till et al.
HUMAN MOLECULAR GENETICS (2015)
Novel agonists for serotonin 5-HT7 receptors reverse metabotropic glutamate receptor-mediated long-term depression in the hippocampus of wild-type and Fmr1 KO mice, a model of Fragile X Syndrome
Lara Costa et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
The role of serotonin 5-HT2A receptors in memory and cognition
Gongliang Zhang et al.
FRONTIERS IN PHARMACOLOGY (2015)
Behavioral analysis of male and female Fmr1 knockout mice on C57BL/6 background
Qi Ding et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
Tobias Buchborn et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia
David A. Martin et al.
NEUROPHARMACOLOGY (2014)
The effect of psilocin on memory acquisition, retrieval, and consolidation in the rat
Lukas Rambousek et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Serotonin dysregulation in Fragile X Syndrome: implications for treatment
Alicia C. Hanson et al.
INTRACTABLE & RARE DISEASES RESEARCH (2014)
The translation of translational control by FMRP: therapeutic targets for FXS
Jennifer C. Darnell et al.
NATURE NEUROSCIENCE (2013)
Decreased tryptophan metabolism in patients with autism spectrum disorders
Luigi Boccuto et al.
MOLECULAR AUTISM (2013)
Serotonin in the Modulation of Neural Plasticity and Networks: Implications for Neurodevelopmental Disorders
Klaus-Peter Lesch et al.
NEURON (2012)
OPINION The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Franz X. Vollenweider et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Carol Kilkenny et al.
PLOS BIOLOGY (2010)
Autism Spectrum Disorder in Fragile X Syndrome: A Longitudinal Evaluation
R. Nick Hernandez et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Advances in the Treatment of Fragile X Syndrome
Randi J. Hagerman et al.
PEDIATRICS (2009)
LSD-assisted psychotherapy in persons suffering from anxiety associated with advanced-stage life threatening diseases. A phase-II, double-blind, placebo-controlled dose-response pilot study
Torsten Passie et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Autism Profiles of Males With Fragile X Syndrome
Susan W. Harris et al.
AMERICAN JOURNAL ON MENTAL RETARDATION (2008)
Brief report: Aggression and stereotypic behavior in males with fragile X syndrome - Moderating secondary genes in a Single Gene disorder
David Hessl et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2008)
The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval
Franz X. Vollenweider et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study
F Hasler et al.
PSYCHOPHARMACOLOGY (2004)
Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine:: involvement of dopamine in the medial prefrontal cortex
R Ventura et al.
BEHAVIOURAL PHARMACOLOGY (2004)
Serotonin in autism and pediatric epilepsies
DC Chugani
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS (2004)
The pharmacology of psilocybin
T Passie et al.
ADDICTION BIOLOGY (2002)
Role of altered brain serotonin mechanisms in autism
DC Chugani
MOLECULAR PSYCHIATRY (2002)
Share Paper
